Gene Assay To Help To Predict Lung Cancer Treatment Resistance, Queen Alexandra Hospital Study

Published: Aug 28, 2009

Bookmark and Share

ScienceDaily (Aug. 28, 2009) — The genes that may contribute to drug resistance in non-small cell lung cancer (NSCLC) can be predicted. Researchers writing in the open access journal BMC Cancer found good correlation between genes believed to be involved in drug sensitivity and resistance and actual in vitro chemosensitivity.

Back to news